Prescription Patterns After the Approval of Dupilumab, Abrocitinib, Baricitinib, and Upadacitinib in Adults with Atopic Dermatitis: A Real-World Evidence from a Multi-Institutional Database in Taiwan

被引:0
|
作者
Lee, Wei-Ting [1 ]
Chang, Kai-Cheng [1 ]
Chen, Hui-Yu [1 ]
机构
[1] Linkou Chang Gung Mem Hosp, Dept Pharm, Taoyuan, Taiwan
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
401
引用
收藏
页码:156 / 156
页数:1
相关论文
共 25 条
  • [21] Dupilumab Demonstrates Rapid Onset of Action in Signs, Symptoms, and Quality of Life in Patients With Atopic Dermatitis: Real-World Evidence From the Large, Nationwide PROLEAD Trial
    Thaci, Diamant
    Bauer, Andrea
    Ertner, Konstantin
    Ramaker-Brunke, Jutta
    Schenck, Florian
    von Kiedrowski, Ralph Michael
    Moeller, Sophie
    Fait, Anja
    Bastian, Mike
    Augustin, Matthias
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 101 - 102
  • [22] Real-World Results of Autologous Stem Cell Transplantation in Newly Diagnosed Patients with Multiple Myeloma: A Multi-Institutional Report from the Canadian Myeloma Research Group (CMRG) Database
    Cote, Julie
    Leblanc, Richard
    Chu, Michael P.
    McCurdy, Arleigh
    Masih-Khan, Esther
    Kardjadj, Moustafa
    Jimenez-Zepeda, Victor H.
    Song, Kevin
    Louzada, Martha L.
    Mian, Hira S.
    White, Darrell
    Sebag, Michael
    Reiman, Anthony
    Stakiw, Julie
    Kotb, Rami
    Bergstrom, Debra
    Aslam, Muhammad
    Kaedbey, Rayan
    Venner, Christopher P.
    Gul, Engin
    Reece, Donna E.
    BLOOD, 2022, 140
  • [23] Real-world outcomes with bortezomib-containing regimens and lenalidomide plus dexamethasone for the treatment of transplant-ineligible multiple myeloma: a multi-institutional report from the Canadian Myeloma Research Group database
    Jimenez-Zepeda, Victor H.
    Venner, Christopher
    McCurdy, Arleigh
    Masih-Khan, Esther
    Atenafu, Eshetu G.
    Sebag, Michael
    Stakiw, Julie
    Song, Kevin
    LeBlanc, Richard
    Reiman, Tony
    Louzada, Martha
    Kotb, Rami
    Gul, Engin
    Reece, Donna
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (03) : 532 - 541
  • [24] Real-World Outcomes with Bortezomib-Containing Regimens and Lenalidomide Plus Dexamethasone for the Treatment of Transplant Ineligible MM Patients: A Multi-Institutional Report from the National Myeloma Canada Research Network (MCRN) Database
    Jimenez-Zepeda, Victor
    Reece, Donna E.
    Arleigh, McCurdy R.
    Masih-Khan, Esther
    Atenafu, Eshetu G.
    Sebag, Michael
    Stakiw, Julie
    Song, Kevin
    Leblanc, Richard
    Reiman, Tony
    Louzada, Martha L.
    Kotb, Rami
    Gul, Engin
    Venner, Christopher P.
    BLOOD, 2018, 132
  • [25] Long-term follow-up of outcomes including progression-free survival 2 in patients with transplant-ineligible multiple myeloma in the real-world practice: A multi-institutional report from the Canadian Myeloma Research Group (CMRG) database
    Kaedbey, Rayan
    Reece, Donna
    Venner, Christopher P.
    Mccurdy, Arleigh
    Su, Jiandong
    Chu, Michael
    Louzada, Martha
    Jimenez-Zepeda, Victor H.
    Mian, Hira
    Song, Kevin
    Sebag, Michael
    Stakiw, Julie
    White, Darrell
    Reiman, Anthony
    Aslam, Muhammad
    Kotb, Rami
    Bergstrom, Debra
    Gul, Engin
    Leblanc, Richard
    EJHAEM, 2024, 5 (03): : 474 - 484